Back to Gastroenterology
Gastroenterologyv1980Evidence-Based

Harvey-Bradshaw Index (HBI) for Crohn's Disease

Stratifies severity of Crohn's disease using only clinical parameters. A simplified version of the Crohn's Disease Activity Index (CDAI) that correlates 93% with CDAI but doesn't require laboratory tests.

Clinical Input Parameters

Range: 0 — 50
Clinical Assessment
Awaiting Parameters
hbi score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Harvey-Bradshaw Index (HBI) for Crohn's Disease is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within gastroenterology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

HBI Score = General well-being (0-4) + Abdominal pain (0-3) + Number of liquid stools (1 point per stool) + Abdominal mass (0-3) + Complications (1 point each)

Clinical Pearls & Practice Notes

  • The HBI has a 93% correlation with the CDAI but is much simpler to use
  • First three parameters (well-being, pain, stools) are assessed for the previous day
  • A reduction of 3 points is considered clinically significant response to treatment
  • Patients scoring ≤3 are very likely to be in remission according to CDAI
  • Does not require laboratory tests unlike CDAI

Evidence & Literature Citations

  1. Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet. 1980 Mar 8;1(8167):514. doi: 10.1016/s0140-6736(80)92767-1.
  2. Peyrin-Biroulet L, Panés J, Sandborn WJ, Vermeire S, Danese S, Feagan BG, et al. Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions. Clin Gastroenterol Hepatol. 2016 Mar;14(3):348-354.e17. doi: 10.1016/j.cgh.2015.06.001.
  3. Gomes P, du Boulay C, Smith CL, Holdstock G. Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut. 1986 Jan;27(1):92-5. doi: 10.1136/gut.27.1.92.

Score Interpretation Ranges

Remission0 – 4 pts

Disease in remission

Mild Disease5 – 7 pts

Mild disease activity

Moderate Disease8 – 16 pts

Moderate disease activity

Severe Disease17 – 100 pts

Severe disease activity

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.